Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Neurology
|
May 5, 1998
Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis
G L Mancardi, F Sardanelli, R C Parodi, et al.
Journal of Neuroimmunology
|
June 16, 2000
Restricted immune responses lead to CNS demyelination and axonal damage
G Mancardi, B A Hart, E Capello, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 6, 2013
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis
A Ghezzi, P Annovazzi, M P Amato, et al.
European Journal of Neurology
|
May 18, 2020
Aggressive multiple sclerosis: a single-centre, real-world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumab
G Boffa, C Lapucci, E Sbragia, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 6, 2000
Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule
H P Brok, A Uccelli, N Kerlero De Rosbo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
January 3, 2006
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis
E Capello, R Saccardi, A Murialdo, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
May 16, 2012
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification
A Laroni, C G Giacomazzi, L Grimaldi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 1, 2011
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience
G L Mancardi, M P Sormani, M Di Gioia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
January 29, 2013
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases
A Ghezzi, P Annovazzi, E Cocco, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Neurology
|
May 5, 1998
Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis
G L Mancardi, F Sardanelli, R C Parodi, et al.
Journal of Neuroimmunology
|
June 16, 2000
Restricted immune responses lead to CNS demyelination and axonal damage
G Mancardi, B A Hart, E Capello, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 6, 2013
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis
A Ghezzi, P Annovazzi, M P Amato, et al.
European Journal of Neurology
|
May 18, 2020
Aggressive multiple sclerosis: a single-centre, real-world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumab
G Boffa, C Lapucci, E Sbragia, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 6, 2000
Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule
H P Brok, A Uccelli, N Kerlero De Rosbo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
January 3, 2006
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis
E Capello, R Saccardi, A Murialdo, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
May 16, 2012
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification
A Laroni, C G Giacomazzi, L Grimaldi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 1, 2011
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience
G L Mancardi, M P Sormani, M Di Gioia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
January 29, 2013
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases
A Ghezzi, P Annovazzi, E Cocco, et al.
Page
of 4